Literature DB >> 10879741

Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation.

M Jacobs1, M W Marino, N Brown, B Abel, L G Bekker, V J Quesniaux, L Fick, B Ryffel.   

Abstract

Tumour necrosis factor-alpha (TNF) plays a central role in the recruitment and activation of mononuclear cells in mycobacterial infection. In the absence of type 1 TNF receptor, Mycobacterium bovis Bacillus Calmette-Guerin (BCG) infection of mice is not contained, leading to fatal disease. Because type 1 TNF receptor binds both TNF and lymphotoxin-a, we used TNF-deficient mice to determine the specific role of TNF in the host resistance to BCG infection. The bacterial burden of the lungs of TNF-deficient mice was substantially increased and the mice succumbed to pneumonia between 8 and 12 weeks with a defective granuloma response. Atypical granulomas developed by 4 weeks expressing low levels of MHC class II, intracellular adhesion molecule (ICAM-1), CD11b and CD11c. Macrophages showed little signs of activation and had low levels of acid phosphatase activity and inducible nitric oxide synthase (INOS) expression. Despite the defective cellular recruitment, the chemokines, monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 (MIP-1alpha), were increased in broncho-alveolar lavage fluid of TNF-deficient mice. The defective host response was corrected by the transplantation of normal bone marrow cells into irradiated TNF-deficient mice. These results demonstrate that TNF derived from hemopoietic cells rather than from mesenchymal origin are essential for a normal host response to BCG infection. Furthermore, TNF dependent expression of adhesion molecules may be essential for the recruitment of mononuclear cells for the formation of bactericidal BCG granulomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879741     DOI: 10.1038/labinvest.3780094

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

2.  Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.

Authors:  A Wellmer; J Gerber; J Ragheb; G Zysk; T Kunst; A Smirnov; W Brück; R Nau
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.

Authors:  Xi Xie; Jin-Wei Chen; Fen Li; Jing Tian; Jie-Sheng Gao; David Zhang
Journal:  Clin Exp Med       Date:  2010-12-16       Impact factor: 3.984

4.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Authors:  Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

5.  A role for c-Myc in regulating anti-mycobacterial responses.

Authors:  Howard C H Yim; James C B Li; John C H Pong; Allan S Y Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-12       Impact factor: 11.205

6.  T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

Authors:  B M Saunders; H Briscoe; W J Britton
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

7.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.

Authors:  Michael B Drennan; Delphine Nicolle; Valerie J F Quesniaux; Muazzam Jacobs; Nasiema Allie; Joseph Mpagi; Cécile Frémond; Hermann Wagner; Carsten Kirschning; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

8.  Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection.

Authors:  Nasiema Allie; Sergei I Grivennikov; Roanne Keeton; Nai-Jen Hsu; Marie-Laure Bourigault; Nathalie Court; Cecile Fremond; Vladimir Yeremeev; Yuriy Shebzukhov; Bernhard Ryffel; Sergei A Nedospasov; Valerie F J Quesniaux; Muazzam Jacobs
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Reactivation of M. tuberculosis infection in trans-membrane tumour necrosis factor mice.

Authors:  Ivy Dambuza; Roanne Keeton; Nasiema Allie; Nai-Jen Hsu; Philippa Randall; Boipelo Sebesho; Lizette Fick; Valerie J F Quesniaux; Muazzam Jacobs
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.